Demonstration: How did hypoglycemic prescriptions become "weight loss artifacts" available for everyone?

"Do you have a 'weight loss needle' here?"

"‘ Weight loss needle ’? Are you talking about Smeglugin? Is it out of stock? You add a group first, and you will notify it in the group when you arrive ..."

"You can buy it if you have it? Don't you go to the hospital for a governor?"

"No, we can open it here, if you have the electronic prescription given by online (pharmaceutical e -commerce platform) ..."

The hypoglycemic prescription transformed into a "weight loss needle" and has been sold in most places to the shortage

The above scene is a dialogue between Li Xu (a pseudonym) in a physical pharmacy in Beijing and has a dialogue with the staff. It is also this dialogue that it can open the corner of the market chaos that is abused and flooded with the "weight loss needle" that is swept across the network.

Initially, Li Xu's focus on the "weight loss needle" started from brushing Xiaohongshu. After watching the use of "weight loss needles" released by various bloggers, "lying thin" for more than a dozen pounds or even tens of pounds. He couldn't help but have a strong curiosity about this magical "weight loss needle".

Various video introduction and use sharing on the short video platform

Searching the keyword "weight loss needle" on major platforms often occur: three results: informal titles of traditional Chinese medicine acupuncture weight loss treatment, botulinum toxin or fat -dissolving needles belonging to the category of medical aesthetics, and in the past two years The so -called Internet celebrity "weight loss needle" of the whole network -a new type of prescription drugs for the treatment of diabetes -1 receptor agonist -like new prescription drugs. At present, the domestic prescription drugs approved in China mainly include polyethylene glycol Losnaptide peptides. , Smeglugin, Licolatic peptide, Essean peptide, du sugar peptide, etc. These injections can also be used for gastric emptying on the basis of lowering blood sugar and lowering blood lipids. Feelings, thereby suppressing appetite, reducing food intake, and a direct weight loss effect.

Various compatibles of Smeglugan peptides on the Xiaohong Book Platforms Platform

In other words, using this "weight loss needle" is not the magical effect of the drug's weight loss, but to make you achieve the effect of "I am hungry and thin" with the psychological feeling of "I am not hungry"!

Of course, in the era of general attention and experience, active resistance to hunger and passiveness is completely different. Presumably, this is also the main reason for the popularity of such products.

After retrieval of major platforms, Li Xu found that among the above -mentioned pancreatic sugar -like peptide -1 receptor agonist needles, the most sought -after is the Smegugu peptide injection (Nuohe Tai Thai ), The drug was approved by the State Drug Administration (NMPA) in April 2021 to treat the risk of cardiovascular adverse events for patients with type 2 diabetes (T2DM) and reducing T2DM with patients with cardiovascular disease. Incident in the medical insurance directory.

This medicine is a long -term medicine. It only needs to be injected once a week. The patient can use it by itself, which is convenient and fast.

In addition to the convenience of use scenarios, the current publicity in the domestic market is also to some extent for the use of super indications and disconnects from prescriptions.

As early as June 4, 2021, the official website of Nordo China released the listing of wegovy (Smeglugin peptide once a week per week) for the US FDA. At least one kind of obesity (BMI ≥ 30kg/㎡) or overweight (BMI ≥ 27kg/㎡) adults with weight -related complications.

Since then, such as "US Food and Drug Administration (FDA) has approved Smeglugin peptide as the use of diet pills, in China, it has also applied for weight loss indications against Smegtugin and has entered the clinical trial stage ..." and so on The news began to fill various media, self -media and traffic platforms.

Online e -commerce price and store promotion

In this context, Smegugu's sales are extremely popular. Li Xu found that the price of the 1.5ml specification of the drug on the online shopping platform was between 650-860 yuan, and the price of 3ml specifications was 1280-1430 yuan at 1280-1430 yuan In between, the price fluctuates According to people familiar with the matter, it is mainly related to the demand for drug consumption in the area where the drug sales institution is located.

In other words, the hypoglycemic prescription medicine may have been sold out of stock in some areas in some areas!

Li Xu retrieved major pharmaceutical e -commerce platforms, online second -hand trading platforms, short video platforms, and inquiries through the registration of medicines and physical pharmacies in the hospital. There is no obvious barrier throughout the online doctor and buyers to directly prescribe electronic prescriptions and sell medicines. In the two physical pharmacies that Li Xu entered in Beijing, Simei Gulingptides were in a state of no stock. One of the pharmacies asked Li Xu to join the store's WeChat group and said that they could come to the store to buy it directly. You need to go to the hospital in advance to prescribe the prescription; although another pharmacy is relatively cautious, it still revealed that it can be sold after registering identity information.

Merchants in the Medical E -commerce Department clearly stated that they can open prescriptions on their behalf

It can be seen that although it is necessary to spend more money, it is easy and convenient to buy Smeglugin peptide, provided that it is available.

In the process, no one cares whether the buyer is used to control blood sugar or lose weight. Whether he meets the applicable criteria of the drug, whether the useful drug safety hazards, the use of drugs, and the response measures after adverse reactions are not notified.

Smeglugin is not absolutely safe, nor is everyone available!

The above has been pointed out that the medicine has strict applicable standards in my country. Related clinical trials of the medicine also clearly states that the proposed adaptation of Smegugu peptide should also be the initial weight index (BMI) ≥28 kg/㎡ patients; or 24 kg/㎡ to to Between 28 kg/㎡, at least one of the merging diseases related to weight -related diseases. As for those who are slightly fat or even weighing, the benefits and risks of using Smeglugin peptide are still unknown. In other words, even in the future, the domestic regulatory authorities approve the use of Smeglugin as a weight loss pill, which is not available to everyone.

Even in the United States that has been approved for weight loss indications, the situation is the case. Wang Shaocheng, deputy chief physician of the Department of Endocrinology, Tsinghua University of Tsinghua University, stated in an interview with the Beijing Daily on August 24, 2022 that for Smegugu peptide, the US Food and Drug Administration (FDA) strictly restricted it for its use for it for it for for Indications for weight loss: patients with adult group weight index (BMI) ≥30kg/㎡; adult overweight people (such as hypertension, type 2 diabetes, high cholesterol) accompanied by at least one of the adult group weight index (BMI); adult overweight people (BMI ≥ 27kg/ ㎡).

Therefore, Wang Shaocheng suggested that doctors cannot blindly apply Smeglugin peptides to lose weight in clinical practice, especially the following groups need to be cautious to use this type of drug: hypoglycemia patients, those who have pancreaticitis, kidney function, thyroid marrow -like shape -like samples Patients with cancer or multiple endocrine tumors, women during pregnancy, and patients with diabetic retinopathy.

In addition, those with severe allergies for Smegutan peptide or auxiliary materials (sodium phosphate dihydrous, propylene glycol, phenol, hydrochloride, sodium hydroxide) shall be discontinued immediately and visited immediately. Patients who use oral drugs during the same period also need to know that because Smeglugin can delay gastric emptying, it may cause the body to slowly absorb oral drugs.

It can be seen that Smegugu peptide is definitely not a "artifact" that "artifacts" that are "safe without side effects and applicable to anyone" claimed by various short videos, notes and self -media authors.

Related search entries stated by the user of Smeglugan

After all, Smeglugin is medicine! According to public information, the common adverse reactions of Smeglugan peptides are gastrointestinal reactions, including satiety, anorexia, nausea, vomiting, stagnation, constipation, etc. In an interview with the Yangtze Evening News, patients also stated that patients had gallstone risks to use Smeglugin peptides. With the popularity of the medicine, there are more and more statements on the consequences of the use of Smegugu peptide on the major traffic platforms and search platforms.

In the face of these facts, and the "ancestral training" of "three poisonous medicines", how can these bloggers, UP masters, and respondents easily violate?

A grain of sand in the industry, a mountain on personal heads

In fact, compared to the spread of the exaggeration of the "cargo party" and the negligence of the platform, the hypoglycemia prescription drug of Smeglugin was used as a "weight loss needle" in the market. The influence brought about is worse and shocking.

In the moment when pharmaceutical technology is not yet developed, the human statement science is far from being fully explored, and the cause of many diseases and treatment is still foggy. At the stage of administration, many prescription medicines must have specific scenes and disease management in the use. The attending doctor must be randomly adjusted according to the patient's disease course and individual conditions in order to achieve relatively optimal efficacy and avoid risks as much as possible. It is far from patients. I and even non -professional can control it by themselves. Therefore, it is necessary to strictly control the prescription medicine and the entire pharmaceutical industry environment.

However, from the phenomenon of super -adaptable sales and abuse of Smegugu peptides as "weight loss needles", it can be seen that there are still many chaos on the sales and use of prescription drugs in my country's pharmaceutical market. To the patient's end, it is possible to bring a tragedy. A grain of sand in the industry falls on everyone and even the family's head, which may be far from a mountain ...

references:

[1] Loss of weight loss science

https://lemon.baidu.com/ala/articleS?q=%E5%87%8F%E8%82%E9%92%88&FROM=5716

[2] The State Drug Administration "April 29, 2021 April 29th

https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20210429162506168.html

[3] Drug Review Center of the State Drug Administration

https://www.cde.org.cn/main/xxgk/listPage/4B5255EB0A84820CEF4CA3E8B6BBE20C

[4] "Beijing Daily" "magic weight loss needle" really returned your devil figure?Is it really no safety risk?https://www.takefoto.cn/news/2022/08/24/10138543.shtml

[5] "Yangtze Evening News" is 10 pounds in two weeks!Is the "weight loss needle" of the fire rim reliable?Professional physician: Actually it is a type of hypoglycemic medicine with weight loss effect

https://baijiahao.baidu.com/s?id=1735880713648800387&WFR=spiDer&FOR=pc

- END -